Hoth Free Cash Flow per Share vs Total Assets Analysis

HOTH Stock  USD 1.38  0.11  7.38%   
Hoth Therapeutics financial indicator trend analysis is much more than just examining Hoth Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hoth Therapeutics is a good investment. Please check the relationship between Hoth Therapeutics Free Cash Flow Per Share and its Total Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.

Free Cash Flow Per Share vs Total Assets

Free Cash Flow per Share vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hoth Therapeutics Free Cash Flow per Share account and Total Assets. At this time, the significance of the direction appears to have pay attention.
The correlation between Hoth Therapeutics' Free Cash Flow per Share and Total Assets is -0.73. Overlapping area represents the amount of variation of Free Cash Flow per Share that can explain the historical movement of Total Assets in the same time period over historical financial statements of Hoth Therapeutics, assuming nothing else is changed. The correlation between historical values of Hoth Therapeutics' Free Cash Flow per Share and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow per Share of Hoth Therapeutics are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Free Cash Flow per Share i.e., Hoth Therapeutics' Free Cash Flow per Share and Total Assets go up and down completely randomly.

Correlation Coefficient

-0.73
Relationship DirectionNegative 
Relationship StrengthWeak

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Total Assets

Total assets refers to the total amount of Hoth Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Hoth Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Hoth Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hoth Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.The current Selling General Administrative is estimated to decrease to about 4.6 M. The current Issuance Of Capital Stock is estimated to decrease to about 9.4 M

Hoth Therapeutics fundamental ratios Correlations

0.790.760.990.89-0.96-0.880.70.970.630.711.00.91-0.690.670.880.860.790.99-0.811.01.00.51-0.81-0.90.67
0.790.990.730.96-0.86-0.960.940.820.170.270.790.76-0.70.610.890.980.990.73-0.730.80.75-0.05-0.73-0.820.25
0.760.990.690.95-0.83-0.960.980.790.150.270.760.77-0.720.680.890.981.00.69-0.750.770.71-0.09-0.75-0.820.18
0.990.730.690.85-0.95-0.840.630.950.680.760.990.87-0.650.630.850.820.731.0-0.780.991.00.59-0.78-0.880.74
0.890.960.950.85-0.94-0.980.910.90.330.410.890.83-0.660.650.940.990.970.85-0.750.890.860.11-0.75-0.90.37
-0.96-0.86-0.83-0.95-0.940.92-0.77-0.97-0.45-0.63-0.97-0.820.61-0.58-0.86-0.91-0.85-0.950.73-0.97-0.96-0.360.730.87-0.64
-0.88-0.96-0.96-0.84-0.980.92-0.93-0.89-0.36-0.41-0.89-0.890.75-0.73-0.95-0.99-0.97-0.840.84-0.89-0.85-0.10.840.93-0.32
0.70.940.980.630.91-0.77-0.930.740.110.260.710.75-0.710.740.870.940.970.63-0.760.710.65-0.14-0.76-0.80.1
0.970.820.790.950.9-0.97-0.890.740.440.610.980.86-0.590.570.820.870.820.95-0.740.980.960.35-0.74-0.830.62
0.630.170.150.680.33-0.45-0.360.110.440.720.60.64-0.580.60.550.320.220.68-0.650.60.660.86-0.65-0.650.6
0.710.270.270.760.41-0.63-0.410.260.610.720.690.53-0.50.540.460.380.290.76-0.570.690.730.87-0.57-0.530.89
1.00.790.760.990.89-0.97-0.890.710.980.60.690.9-0.660.650.870.860.80.99-0.81.00.990.48-0.8-0.890.67
0.910.760.770.870.83-0.82-0.890.750.860.640.530.9-0.820.850.930.850.810.87-0.940.90.880.35-0.94-0.950.37
-0.69-0.7-0.72-0.65-0.660.610.75-0.71-0.59-0.58-0.5-0.66-0.82-0.91-0.82-0.72-0.73-0.650.96-0.68-0.64-0.330.960.82-0.28
0.670.610.680.630.65-0.58-0.730.740.570.60.540.650.85-0.910.830.70.70.63-0.950.660.620.31-0.95-0.840.19
0.880.890.890.850.94-0.86-0.950.870.820.550.460.870.93-0.820.830.950.930.85-0.90.870.850.24-0.9-0.980.32
0.860.980.980.820.99-0.91-0.990.940.870.320.380.860.85-0.720.70.950.990.82-0.790.870.830.07-0.79-0.910.3
0.790.991.00.730.97-0.85-0.970.970.820.220.290.80.81-0.730.70.930.990.73-0.780.80.75-0.04-0.78-0.870.21
0.990.730.691.00.85-0.95-0.840.630.950.680.760.990.87-0.650.630.850.820.73-0.780.991.00.59-0.78-0.880.74
-0.81-0.73-0.75-0.78-0.750.730.84-0.76-0.74-0.65-0.57-0.8-0.940.96-0.95-0.9-0.79-0.78-0.78-0.81-0.77-0.381.00.92-0.34
1.00.80.770.990.89-0.97-0.890.710.980.60.691.00.9-0.680.660.870.870.80.99-0.810.990.48-0.81-0.90.67
1.00.750.711.00.86-0.96-0.850.650.960.660.730.990.88-0.640.620.850.830.751.0-0.770.990.56-0.77-0.880.72
0.51-0.05-0.090.590.11-0.36-0.1-0.140.350.860.870.480.35-0.330.310.240.07-0.040.59-0.380.480.56-0.38-0.350.84
-0.81-0.73-0.75-0.78-0.750.730.84-0.76-0.74-0.65-0.57-0.8-0.940.96-0.95-0.9-0.79-0.78-0.781.0-0.81-0.77-0.380.92-0.34
-0.9-0.82-0.82-0.88-0.90.870.93-0.8-0.83-0.65-0.53-0.89-0.950.82-0.84-0.98-0.91-0.87-0.880.92-0.9-0.88-0.350.92-0.38
0.670.250.180.740.37-0.64-0.320.10.620.60.890.670.37-0.280.190.320.30.210.74-0.340.670.720.84-0.34-0.38
Click cells to compare fundamentals

Hoth Therapeutics Account Relationship Matchups

Hoth Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.8M5.2M11.0M6.8M7.8M5.1M
Other Current Liab36.2K182.7K506.8K692.7K796.7K836.5K
Total Current Liabilities440.1K312.1K867.8K1.4M1.6M1.7M
Total Stockholder Equity2.4M4.6M9.9M5.1M5.9M4.3M
Net Tangible Assets154.7K2.4M4.6M9.9M11.4M11.9M
Net Debt(1.7M)(2.6M)(8.5M)(6.4M)(5.8M)(5.5M)
Retained Earnings(12.2M)(19.4M)(33.7M)(45.1M)(40.6M)(38.6M)
Accounts Payable403.9K129.5K361.0K695.0K799.2K839.2K
Cash1.7M2.6M8.5M6.4M7.4M3.8M
Non Current Assets Total201.0K460K410K33K38.0K36.1K
Non Currrent Assets Other200K50K410K33K38.0K36.1K
Cash And Short Term Investments2.5M4.7M10.4M6.6M7.6M4.7M
Common Stock Shares Outstanding366.6K494.5K893.2K1.2M1.1M1.7M
Liabilities And Stockholders Equity2.8M5.2M11.0M6.8M7.8M5.1M
Non Current Liabilities Total403.9K285K235K250K287.5K250.1K
Other Stockholder Equity14.6M24.1M43.6M50.2M57.7M60.6M
Total Liab440.1K597.1K1.1M1.6M1.9M2.0M
Net Invested Capital2.4M4.6M9.9M5.1M5.9M4.3M
Total Current Assets2.6M4.8M10.6M6.7M7.7M4.8M
Net Working Capital2.2M4.5M9.7M5.3M6.1M4.2M
Common Stock1.0K1.3K2.4K130.0149.5142.03
Other Current Assets140.6K89.8K94.0M88.5K101.7K96.6K
Capital Stock1.0K1.3K2.4K130.0149.5142.03
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hoth Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hoth Therapeutics' short interest history, or implied volatility extrapolated from Hoth Therapeutics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for Hoth Stock analysis

When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.71)
Return On Assets
(0.54)
Return On Equity
(1.01)
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.